92 related articles for article (PubMed ID: 3036727)
1. Alzheimer's disease and the pivotal role of the hypothalamus and the intrinsic opioid system.
Iacono RP; Sandyk R
Int J Neurosci; 1987 Feb; 32(3-4):710-4. PubMed ID: 3036727
[TBL] [Abstract][Full Text] [Related]
2. [Olfactory disorders in Alzheimer's disease and in Parkinson's disease. Review of the literature].
Norès JM; Biacabe B; Bonfils P
Ann Med Interne (Paris); 2000 Mar; 151(2):97-106. PubMed ID: 10855362
[TBL] [Abstract][Full Text] [Related]
3. [Neurotransmitter anomalies in Alzheimer's disease].
Berger B
Rev Neurol (Paris); 1984; 140(10):539-52. PubMed ID: 6150545
[TBL] [Abstract][Full Text] [Related]
4. Nerve growth factor and Alzheimer's disease.
Hefti F; Weiner WJ
Ann Neurol; 1986 Sep; 20(3):275-81. PubMed ID: 3532929
[TBL] [Abstract][Full Text] [Related]
5. [Neurotransmitters in Alzheimer's disease].
Manzano-Palomo S; De la Morena-Vicente MA; Barquero MS
Rev Neurol; 2006 Mar 16-31; 42(6):350-3. PubMed ID: 16575771
[TBL] [Abstract][Full Text] [Related]
6. Neuropathologic changes in Alzheimer's disease.
Wenk GL
J Clin Psychiatry; 2003; 64 Suppl 9():7-10. PubMed ID: 12934968
[TBL] [Abstract][Full Text] [Related]
7. Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. III. The basal forebrain compared with other subcortical areas.
Arendt T; Brückner MK; Bigl V; Marcova L
J Comp Neurol; 1995 Jan; 351(2):223-46. PubMed ID: 7699112
[TBL] [Abstract][Full Text] [Related]
8. Pathological and biochemical alterations of astrocytes in ovariectomized rats injected with D-galactose: a potential contribution to Alzheimer's disease processes.
Hua X; Lei M; Ding J; Han Q; Hu G; Xiao M
Exp Neurol; 2008 Apr; 210(2):709-18. PubMed ID: 18289535
[TBL] [Abstract][Full Text] [Related]
9. Neurotransmitter replacement therapy in Alzheimer's disease.
Mohr E; Mendis T; Rusk IN; Grimes JD
J Psychiatry Neurosci; 1994 Jan; 19(1):17-23. PubMed ID: 7908537
[TBL] [Abstract][Full Text] [Related]
10. Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease.
Pearce BR; Palmer AM; Bowen DM; Wilcock GK; Esiri MM; Davison AN
Neurochem Pathol; 1984-1985 Winter; 2(4):221-32. PubMed ID: 6085697
[TBL] [Abstract][Full Text] [Related]
11. Neuropathologic changes in Alzheimer's disease: potential targets for treatment.
Wenk GL
J Clin Psychiatry; 2006; 67 Suppl 3():3-7; quiz 23. PubMed ID: 16649845
[TBL] [Abstract][Full Text] [Related]
12. The nucleus basalis of Meynert in neurological disease: a quantitative morphological study.
Rogers JD; Brogan D; Mirra SS
Ann Neurol; 1985 Feb; 17(2):163-70. PubMed ID: 3883886
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease and hypothalamic-mediated endorphinergic mechanisms.
Sandyk R; Iacono RP
Neuroscience; 1986 Oct; 19(2):667-8. PubMed ID: 3022188
[No Abstract] [Full Text] [Related]
14. Alzheimer's neuroborreliosis with trans-synaptic spread of infection and neurofibrillary tangles derived from intraneuronal spirochetes.
MacDonald AB
Med Hypotheses; 2007; 68(4):822-5. PubMed ID: 17055667
[TBL] [Abstract][Full Text] [Related]
15. Excitotoxicity and new antiglutamatergic strategies in Parkinson's disease and Alzheimer's disease.
Koutsilieri E; Riederer P
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S329-31. PubMed ID: 18267259
[TBL] [Abstract][Full Text] [Related]
16. The hypothalamus in Parkinson's disease.
Sandyk R; Iacono RP
Int J Neurosci; 1987 Apr; 33(3-4):257-9. PubMed ID: 3036732
[No Abstract] [Full Text] [Related]
17. [Current data on the anatomy and physiopathology of Alzheimer's disease (Alzheimer-type senile dementia--ATSD)].
Fărcăşel L
Rev Med Chir Soc Med Nat Iasi; 1988; 92(2):289-92. PubMed ID: 2847267
[No Abstract] [Full Text] [Related]
18. The role of the p75 neurotrophin receptor in cholinergic dysfunction in Alzheimer's disease.
Coulson EJ; May LM; Sykes AM; Hamlin AS
Neuroscientist; 2009 Aug; 15(4):317-23. PubMed ID: 19458382
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptides in Alzheimer's disease. Clinical implications.
Mazurek MF; Beal MF; Martin JB
Neurol Clin; 1986 Nov; 4(4):753-68. PubMed ID: 3025582
[TBL] [Abstract][Full Text] [Related]
20. Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. II. Ageing, Korsakoff's disease, Parkinson's disease, and Alzheimer's disease.
Arendt T; Brückner MK; Bigl V; Marcova L
J Comp Neurol; 1995 Jan; 351(2):189-222. PubMed ID: 7535318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
